The cellular targets of IL‐25/IL‐33/TSLP vary from innate/adaptive immune cells to lung structural cells, whereas the master target cells that mediate pro‐inflammatory and pro‐fibrotic effect of IL‐25/IL‐33/TSLP on IPF are still undermined. The gene discussed is IL33; the disease is idiopathic pulmonary fibrosis.